Delivery Order SPE2DR25D3013-SPE2DR26F6T5F
- Not listed
- The Defense Logistics Agency awarded a $14,428.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. The delivery order represents a typical...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This non-set-aside, firm fixed-price contract is scheduled for completion by October 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,428.06 on September 15, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $15,204.96 to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 16, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $14.4K to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Tabrecta (entinostat) 200 mg tablets in a quantity of 56 units. This firm fixed-price, competitively awarded delivery order is expected to be completed by November 12, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TABRECTA 200 mg tablets (56-count units) valued at $7,214.03 under a firm fixed-price contract type. The award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TABRECTA 200 mg tablets in quantities of 56 units. This is a firm fixed-price contract with a ceiling value of $14.4K and an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and represents a competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- This federal contract award, with a value of $14,428.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025, and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $12,868.60 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562954453 TABRECTA 200 MG TABLET UU 56S. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by December 21, 2023. No set-aside designation was applied to this order, which was awarded against an existing indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,428.06, is a delivery order for the provision of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6T5FDelivery Order
The Defense Logistics Agency awarded a $15,204.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tabrecta 200 mg tablets (56-count units) on December 1, 2025, with an ultimate completion date of December 22, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December 2026. The award utilized no set-aside designation and was competitively awarded. Tabrecta is a prescription medication used for certain types of cancer treatment, representing the type of specialized pharmaceutical products that DLA procures to support military healthcare systems and veteran medical services. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and has demonstrated significant capacity to fulfill DLA requirements across a broad range of medications and medical supplies. The company's SPE2DX contract enables it to supply critical pharmaceutical commodities—including brand-name and generic drugs, vaccines, and specialty medications—to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. This delivery order exemplifies the routine fulfillment of medical supply needs through DLA's established pharmaceutical prime vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 11/30/25 |